In vitro susceptibility of canine corneal bacterial pathogens to three cross-linking protocols.

Abstract

OBJECTIVE: To assess in vitro antibacterial efficacy of three cross-linking (XL) protocols on bacteria associated with canine ulcerative keratitis. METHODS: Three XL protocols: UVA 3&#xa0;mW/cmfor 60&#x2009;min, UVA 3&#xa0;mW/cmfor 30&#x2009;min, and UVA 30&#x2009;mW/cmfor 3&#xa0;min with and without application of riboflavin and a riboflavin-only protocol were performed in vitro on the four most common bacterial genera isolated from cases of canine ulcerative keratitis treated at Dick White Referrals, UK. Zones of bacterial growth inhibition (GIZ) associated with treatment were measured and compared. RESULTS: The four most common isolates were Pseudomonas aeruginosa (PA) (48/140, 34.3%), Streptococcus spp. (32/140, 22.9%), Staphylococcus spp. (24/140, 17.1%) and Escherichia coli (EC) (11/140, 7.9%). PA, EC, Streptococcus canis (SC), and Staphylococcus pseudintermedius (SP), isolated from canine corneas, were selected for testing. EC and SC demonstrated growth inhibition following all UVA/riboflavin protocols. PA and SP only displayed growth inhibition following the 60&#x2009;min UVA/riboflavin protocol. GIZ areas for 60&#x2009;min UVA/riboflavin protocols were significantly greater than 30 and 3&#xa0;min UVA/riboflavin protocols (p&#x2009;<&#x2009;.01) and there was no significant difference between 30 and 3&#xa0;min UVA/riboflavin protocols. In respect to GIZ areas, EC was significantly more susceptible to XL than SP (p&#xa0;=&#xa0;<.01). CONCLUSIONS: All UVA/riboflavin XL protocols caused growth inhibition of EC and SC in vitro. PA and SP did not show clear growth inhibition in vitro following exposure to XL protocol settings of UVA 3&#xa0;mW/cmfor 30&#x2009;min and UVA 30&#x2009;mW/cmfor 3&#xa0;min.